EP2815753
LYFJASAMSETNING SEM HÆGT ER AÐ NOTA TIL INNTÖKU OG INNIHELDUR A,A,A-TRÍFLÚRTÝMÍDÍN OG 5-KLÓR-6-(2-IMÍNÓPÝRRÓLIDÍN-1-ÝL)METÝL-2,4 (1H,3H)-PÝRIMÍDÍNDÍÓNHÝDRÓKLÓRÍÐ
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
14.2.2013EP published:
16.5.2018EP application number:
13749171.8
EP translation filed:
20.7.2018Grant published:
15.8.2018EPO information:
European Patent Register
Max expiry date:
13.2.2033Expiry date:
13.2.2027Next due date:
28.2.2027
Title:
ORAL ADMINISTRABLE PHARMACEUTICAL COMPOSITION
Timeline
Today
14.2.2013EP application
16.5.2018EP Publication
20.7.2018Translation submitted
15.8.2018Registration published
13.2.2027Expires
Owner
Name:
Taiho Pharmaceutical Co., Ltd.Address:
1-27, Kandanishiki-cho, 101-8444, Chiyoda-ku, Tokyo, JP
Inventor
Name:
OHNISHI, YoshitoAddress:
Tokushima-shi,Tokushima, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
2012031143Date:
15.2.2012Country:
JP
Classification
Categories:
A61K 31/7072, A61K 9/20, A61K 9/28, A61K 31/513, A61K 47/10, A61K 47/26, A61K 47/32, A61K 47/36, A61K 47/38, A61P 35/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.1.2019
Expires: 13.2.2020
Payer: Árnason Faktor
Number: 8
Paid: 14.1.2020
Expires: 13.2.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.1.2021
Expires: 13.2.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.1.2022
Expires: 13.2.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.1.2023
Expires: 13.2.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.1.2023
Expires: 13.2.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.1.2024
Expires: 13.2.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 16.1.2025
Expires: 13.2.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 13.2.2026
Expires: 13.2.2027
Payer: Árnason Faktor ehf.